Evidence map›Paper›PMID 35284722›Full record

ArticleACS omega2022

Doxorubicin-NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells.

Cristina Parisi, Francesca Moret, Aurore Fraix, Luca Menilli, Mariacristina Failla, Federica Sodano, Claudia Conte, Fabiana Quaglia, Elena Reddi, Salvatore Sortino

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. NO-PDT and chemotherapy: spatiotemporal control to achieve therapeutic synergy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Cristina ParisiDepartment of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy.
Francesca MoretDepartment of Biology, University of Padova, I-35131 Padova, Italy.ORCID https://orcid.org/0000-0002-1534-3714
Aurore FraixDepartment of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy.
Luca MenilliDepartment of Biology, University of Padova, I-35131 Padova, Italy.ORCID https://orcid.org/0000-0003-2774-6411
Mariacristina FaillaDepartment of Science and Drug Technology, University of Torino, I-10125 Torino, Italy.
Federica SodanoDepartment of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy.ORCID https://orcid.org/0000-0003-2013-4893
Claudia ConteDrug Delivery Laboratory, Department of Pharmacy, University of Napoli Federico II, I-80131 Napoli, Italy.
Fabiana QuagliaDrug Delivery Laboratory, Department of Pharmacy, University of Napoli Federico II, I-80131 Napoli, Italy.ORCID https://orcid.org/0000-0001-6223-0782
Elena ReddiDepartment of Biology, University of Padova, I-35131 Padova, Italy.
Salvatore SortinoDepartment of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy.ORCID https://orcid.org/0000-0002-2086-1276
University of Catania · ITUniversity of Padua · ITUniversity of Naples Federico II · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological activity of a molecular hybrid (

Identifiers

PMID35284722
PMCPMC8908524
OpenAlexW4213453448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.